Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias.
about
Hyperactive Wnt signaling changes the developmental potential of embryonic lung endodermExpression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation.Beta-catenin: a transforming actor on many stagesProteotypic classification of spontaneous and transgenic mammary neoplasmsApc mutation enhances PyMT-induced mammary tumorigenesisActivation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumorsBIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanismsActivation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiationUse of fluorescence-activated vesicle sorting for isolation of Naked2-associated, basolaterally targeted exocytic vesicles for proteomics analysisRb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesisGenetic mechanisms in Apc-mediated mammary tumorigenesisPhenotypic plasticity in normal breast derived epithelial cells.EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesisKey signaling nodes in mammary gland development and cancer: β-catenin.Targeting the embryonic gene Cripto-1 in cancer and beyond.Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesisBeta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands.Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesisImpact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.Transdetermination: Drosophila imaginal disc cells exhibit stem cell-like potencyRole of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.Identity deception: not a crime for a stem cell.Runx2 contributes to the regenerative potential of the mammary epithelium.Cardiac stem cells and mechanisms of myocardial regeneration.A bioluminescence reporter mouse that monitors expression of constitutively active β-cateninIGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumorsThree genes control the timing, the site and the size of blastema formation in Drosophila.Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.Wnt signaling in breast organogenesis.Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.The role of WNT10B in physiology and disease.Wnt signalling in murine postnatal mammary gland development.Molecular alterations in metaplastic breast carcinoma.Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.
P2860
Q24791466-A70EED31-89F4-448C-B9D7-2B423EECF5F9Q24794618-676A1FDD-72EA-4197-91D3-E038F3173D77Q24795343-37D82952-0CD6-4FAA-ABB2-3D6DB839C089Q24795869-1A4C361B-2572-42C4-993D-173F8517B9B1Q27310772-3B077C7A-0F0D-4814-96FA-DDA7564E3ED0Q27437626-43CDF2F8-11D8-4183-A29E-55E1051E0637Q28510331-D6B6A4FF-275D-4540-869D-190A85E8239DQ28584971-05D9C5D2-DD33-46C5-AB0D-820A70E39018Q28910487-74469FC9-9FEA-4460-A21F-4E75C8824684Q30496322-3F379A55-8F27-47E1-A92E-E4FA56DB2575Q33371124-8C7D7F13-6C11-41C5-9598-1786CEDFF7BDQ33406237-517D4085-C189-40D6-9FB7-B7C8934B3EA8Q33789073-77BAA181-0F98-407D-AEAD-678D968C96CBQ34288822-2362EDE0-D8F1-4F5A-ADEC-37F1EF4EA899Q34334394-9D4AC92D-ADA8-44D5-8F75-3C5D13683F0BQ34613461-0BAEF2E6-E485-4237-9B08-25061796531BQ34688767-6ACCDE30-641D-47DF-874F-89550291D3D1Q34698214-2140222C-9B0A-4607-97E3-9F7B73426755Q35085039-B65B441B-FFD2-440C-AD71-C5DCAF3CD0D6Q35098096-B756CC80-3222-4CE3-B107-41803F629654Q35641656-E65E26D1-9D8D-483A-A20C-19EEB22925F5Q35789027-1FC93C61-6EFE-4A0F-B4C9-2278FAAA15EDQ35815397-9639D14D-65E3-46BC-97CE-A95DB2986250Q35964137-307ECDEB-DA15-40EB-8541-B7CB5C11FEE8Q36025249-084980AF-391D-4DAA-8DC5-B7308DC29F06Q36044923-B222F10D-7670-4312-B526-77F8005C54B6Q36124315-5CF9C89A-D8EE-4A45-9CC1-C48CEC9C4876Q36189136-43ADD9E2-E217-4AC9-AD34-37B03190CE38Q36267790-3885A4A7-8369-4ABE-84EE-1808EBC73188Q36295368-2917628A-4CA3-48B0-93D0-7B213CF90D5BQ36664343-52278BD4-72F5-411A-9FE7-E2B2B9A07E2CQ36790002-1A99F291-3568-4FDF-9A50-1E6C61D06CFBQ36798949-31FF69D9-5D95-432F-AF10-39C278EEE876Q37080183-DCC0B29B-EE4A-4840-875F-974BB58A6354Q37259094-A7202A06-4D7F-4C19-9ABD-897E29040921Q37394982-5E8125EA-0878-4D4C-8E3D-CCCE1A47A12EQ37859090-291E3246-ADC2-4C78-A45E-4EF126219C4EQ37868761-6DEA6010-587F-40B0-BE60-BF4E17BFD1BDQ38078338-45BF2149-5588-41D5-8D14-16F4F70A3360Q39160945-EB86659F-EAAB-41FE-94D3-CF4B574A53D1
P2860
Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@ast
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@en
type
label
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@ast
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@en
prefLabel
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@ast
Activation of beta -catenin si ...... rmis and squamous metaplasias.
@en
P2093
P2860
P356
P1476
Activation of beta -catenin si ...... ermis and squamous metaplasias
@en
P2093
Fabienne Le Provost
Fotini Gounari
Harald von Boehmer
Jonathan M Shillingford
Keiko Miyoshi
Khashayarsha Khazaie
Makoto M Taketo
Robert D Cardiff
Roderick Bronson
P2860
P304
P356
10.1073/PNAS.012414099
P407
P577
2002-01-02T00:00:00Z